[ad_1] Profits are growing again, and the Federal Reserve looks as if it will start cutting rates sometime this year. It is an unusual combination and, for the stock market,…
Tag: Merck &
Merck to Buy Harpoon Therapeutics for $680 Million
[ad_1] Merck & Co.has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680 million. Merck on Monday said it will pay $23 a share in cash…
Moderna, Merck vaccine with Keytruda cuts risk of deadly skin cancer returning in half, data says
[ad_1] An exterior view of Moderna’s clinical manufacturing facility. David L. Ryan | Boston Globe | Getty Images Moderna and Merck‘s experimental cancer vaccine, when used in combination with Merck’s…
Merck Animal Health Receives Positive CVMP Opinion for an Injectable Formulation of BRAVECTO® (Fluralaner) for Use in Dogs
[ad_1] This section is Partnership Content supplied The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia…
Merck MS Drug Fails to Meet Target of Late-Stage Trials
[ad_1] Merck’s multiple sclerosis drug evobrutinib didn’t meet a key goal in late-stage trials. The German pharmaceutical company’s phase 3 clinical trials for the drug did not achieve their primary…
Merck KGaA suffers major blow as MS drug fails in late-stage trials
[ad_1] [1/2]A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, 2016. REUTERS/Ralph Orlowski/File Photo Acquire Licensing Rights FRANKFURT, Dec 5 (Reuters) – Germany’s…
Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck
[ad_1] SHANGHAI, Dec. 4, 2023 /PRNewswire/ — On 4 Dec. 2023, Abbisko Therapeutics announced that it has entered into a licensing agreement with Merck, a leading science and technology company…
The Stocks That AI Mania Left Behind
[ad_1] This was supposed to be the year value stocks shined. Then AI mania took over and ran away with the spotlight. Shares of big tech companies are surging this…
Earnings Estimates Are Falling. These Two Companies Are Shouldering the Blame.
[ad_1] Wall Street has slashed its estimates for corporate profits in the final months of 2023. Yet investors appear to be taking the shifting picture in stride, partly because much…